Go Deep
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,193 | 85.2 | 5.60 | 0.15 | 1,871.10 |
Tatva Chintan Pharma Chem Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,670,550,000.0 | 1,341,440,000.0 | 1,313,340,000.0 | 1,235,160,000.0 |
| Net Profit | 159,810,000.0 | 103,210,000.0 | 151,650,000.0 | 99,170,000.0 |
| EPS | 6.8 | 4.4 | 6.5 | 4.2 |
Tatva Chintan Pharma Chem Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 5,006,200,000.0 | 3,799,010,000.0 | 3,904,950,000.0 | 4,208,910,000.0 |
| Net Profit | 420,540,000.0 | 57,130,000.0 | 303,540,000.0 | 454,870,000.0 |
| EPS | 18.0 | 2.4 | 13.3 | 20.5 |
Tatva Chintan Pharma Chem Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 10,036,940,000.0 | 8,362,490,000.0 | 8,187,180,000.0 | 7,588,570,000.0 | — |
| Total Liabilities | 2,219,350,000.0 | 974,250,000.0 | 816,360,000.0 | 2,440,660,000.0 | — |
| Total Equity | 7,817,590,000.0 | 7,388,240,000.0 | 7,370,820,000.0 | 5,147,910,000.0 | — |
Owes vs Owns
Tatva Chintan Pharma Chem Limited owed ₹0.22 for every ₹1 it owned in Mar 2026, down from ₹0.32 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.22× | 0.12× | 0.10× | 0.32× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Tatva Chintan Pharma Chem Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 0.6%Receivables 11.9%Inventory 19.5%Fixed assets (tangible) 62.5%Intangible assets 0.7%Other assets 4.4%
How it's funded — Mar 2026
Short-term debt 11.5%Payables 5.8%Other liabilities 4.3%Shareholders' equity 77.9%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.1 | 11.7 | 45.7 | 41.2 |
| Receivables | 119.0 | 89.5 | 69.9 | 84.4 |
| Inventory | 196.1 | 134.0 | 152.8 | 162.5 |
| Fixed assets (tangible) | 627.5 | 547.1 | 499.5 | 426.5 |
| Intangible assets | 6.8 | 5.9 | 4.0 | 0.5 |
| Long-term investments | 4.4 | 0.0 | 0.0 | 2.8 |
| Other assets | 43.8 | 48.1 | 47.0 | 40.9 |
| Liabilities & equity | ||||
| Short-term debt | 115.4 | 36.4 | 13.6 | 166.0 |
| Long-term debt | 5.0 | 0.0 | 0.6 | 4.2 |
| Payables | 58.2 | 32.7 | 45.0 | 32.2 |
| Other liabilities | 43.3 | 28.3 | 22.3 | 41.6 |
| Shareholders' equity | 781.8 | 738.8 | 737.1 | 514.8 |
| Net tangible assets | 774.9 | 732.9 | 733.1 | 514.3 |
Tatva Chintan Pharma Chem Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 314,890,000.0 | 247,740,000.0 | 980,440,000.0 | 277,830,000.0 | — |
| Investing Activities | -1,158,420,000.0 | -653,840,000.0 | -1,205,400,000.0 | -1,011,440,000.0 | — |
| Financing Activities | 789,320,000.0 | 165,930,000.0 | 305,190,000.0 | 377,950,000.0 | — |